CoChat

Comparative efficacy of hypnotics in young and middle-aged adults with insomnia: a systematic review and network meta-analysis

Hasan, Faizul, Lee, Hsin-Chien, Chen, Pin-Yuan, Wang, Yi-Han, Yuliana, Lia Taurussia, Romadlon, Debby Syahru, Tu, Yu-Kang, Chiu, Hsiao-Yean · 2023 · Sleep and Breathing
Cited by 9

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11325-023-02812-5

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 35

  1. Adams RJ, Appleton SL, Taylor AW, Gill TK, Lang C, McEvoy RD et al (2017) Sleep health of Australian adults in 2016: results of the 2016 Sleep Health Foundation national survey. Sleep Health 3(1):35–42 · DOI · Paper page
  2. Cao XL, Wang SB, Zhong BL, Zhang L, Ungvari GS, Ng CH et al (2017) The prevalence of insomnia in the general population in China: a meta-analysis. PLoS One 12(2):e0170772 · DOI · Paper page
  3. Itani O, Kaneita Y, Munezawa T, Mishima K, Jike M, Nakagome S et al (2016) Nationwide epidemiological study of insomnia in Japan. Sleep Med 25:130–138 · DOI
  4. Kerkhof GA (2017) Epidemiology of sleep and sleep disorders in the Netherlands. Sleep Med 30:229–239 · DOI · Paper page
  5. Basta M, Simos P, Bertsias A, Duijker G, Zaganas I, Koutentaki E et al (2018) Association between insomnia symptoms and cognitive impairment in the Cretan Aging Cohort. Eur Geriatr Med 9(5):697–706 · DOI
  6. Leger D, Bayon V, Ohayon MM, Philip P, Ement P, Metlaine A et al (2014) Insomnia and accidents: cross-sectional study (EQUINOX) on sleep-related home, work and car accidents in 5293 subjects with insomnia from 10 countries. J Sleep Res 23(2):143–152 · DOI · Paper page
  7. Perils ML, Smith MT (2008) How can we make CBT-I and other BSM services widely available? J Clin Sleep Med 4(1):11–13 · DOI
  8. Holbrook AM, Crowther R, Lotter A, Cheng C, King D (2000) Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 162(2):225–233
  9. Kishi T, Matsunaga S, Iwata N (2015) Suvorexant for primary insomnia: a systematic review and meta-analysis of randomized placebo-controlled trials. PLoS One 10(8):e0136910 · DOI · Paper page
  10. Kuriyama A, Honda M, Hayashino Y (2014) Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis. Sleep Med 15(4):385–392 · DOI · Paper page
  11. Kuriyama A, Tabata H (2017) Suvorexant for the treatment of primary insomnia: a systematic review and meta-analysis. Sleep Med Rev 35:1–7 · DOI
  12. Liu J, Wang LN (2012) Ramelteon in the treatment of chronic insomnia: systematic review and meta-analysis. Int J Clin Pract 66(9):867–873 · DOI
  13. Winkler A, Auer C, Doering BK, Rief W (2014) Drug treatment of primary insomnia: a meta-analysis of polysomnographic randomized controlled trials. CNS Drugs 28(9):799–816 · DOI
  14. Dündar Y, Dodd S, Strobl J, Boland A, Dickson R, Walley T (2004) Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Hum Psychopharmacol 19(5):305–322 · DOI · Paper page
  15. Yue J-L, Chang X-W, Zheng J-W, Shi L, Xiang Y-J, Que J-Y et al (2023) Efficacy and tolerability of pharmacological treatments for insomnia in adults: a systematic review and network meta-analysis. Sleep Med Rev 68:101746. https://doi.org/10.1016/j.smrv.2023.101746 · DOI
  16. Wang L, Pan Y, Ye C, Guo L, Luo S, Dai S et al (2021) A network meta-analysis of the long-and short-term efficacy of sleep medicines in adults and older adults. Neurosci Biobehav Rev 131:489–496 · DOI
  17. Lie JD, Tu KN, Shen DD, Wong BM (2015) Pharmacological treatment of insomnia. Pharma Ther 40(11):759
  18. Abad VC, Guilleminault C (2018) Insomnia in elderly patients: recommendations for pharmacological management. Drugs Aging 35(9):791–817 · DOI · Paper page
  19. Neutel CI, Skurtveit S, Berg C (2012) What is the point of guidelines? Benzodiazepine and z-hypnotic use by an elderly population. Sleep Med 13(7):893–897 · DOI
  20. Chiu H-Y, Lee H-C, Liu J-W, Hua S-J, Chen P-Y, Tsai P-S et al (2021) Comparative efficacy and safety of hypnotics for insomnia in older adults: a systematic review and network meta-analysis. Sleep 44(5):zsaa260 · DOI
  21. Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C et al (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162(11):777–784 · DOI · Paper page
  22. Dujardin S, Pijpers A, Pevernagie D (2018) Prescription drugs used in insomnia. Sleep Med Clin 13(2):169–182 · DOI
  23. Varma S (2016) Benzodiazepines and hypnotics. Medicine 44(12):764–767 · DOI
  24. Su YX, Tu YK (2018) Statistical approaches to adjusting weights for dependent arms in network meta-analysis. Res Synth Methods 9(3):431–440 · DOI
  25. Chaimani A, Higgins JP, Mavridis D, Spyridonos P, Salanti G (2013) Graphical tools for network meta-analysis in STATA. PLoS One 8(10):e76654 · DOI · Paper page
  26. Lu G, Ades AE (2004) Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 23(20):3105–3124 · DOI · Paper page
  27. Shim, S. R., Kim, S. J., Lee, J., & Rücker, G. (2019). Network meta-analysis: application and practice using R software. Epidemiol Health, 41:e2019013. https://doi.org/10.1016/j.smrv.2023.10174610.4178/epih.e2019013 · doi:10.1016/j.smrv.2023.10174610.4178/epih.e2019013
  28. Dolder CR, Nelson MH (2008) Hypnosedative-induced complex behaviours : incidence, mechanisms and management. CNS Drugs 22(12):1021–1036 · DOI
  29. Dauvilliers Y, Zammit G, Fietze I, Mayleben D, SeboekKinter D, Pain S et al (2020) Daridorexant, a new dual orexin receptor antagonist to treat insomnia disorder. Ann Neurol 87(3):347–356 · DOI
  30. Xue T, Wu X, Chen S, Yang Y, Yan Z, Song Z et al (2022) The efficacy and safety of dual orexin receptor antagonists in primary insomnia: a systematic review and network meta-analysis. Sleep Med Rev 61:101573 · DOI
  31. Treiber A, de Kanter R, Roch C, Gatfield J, Boss C, von Raumer M et al (2017) The use of physiology-based pharmacokinetic and pharmacodynamic modeling in the discovery of the dual orexin receptor antagonist ACT-541468. J Pharmacol Exp Ther 362(3):489–503 · DOI
  32. Morin CM, Inoue Y, Kushida C, Poyares D, Winkelman J, Members GC (2021) Endorsement of European guideline for the diagnosis and treatment of insomnia by the World Sleep Society. Sleep Med 81:124–126 · DOI · Paper page
  33. Sekhon BS (2013) Exploiting the power of stereochemistry in drugs: an overview of racemic and enantiopure drugs. J Mod Med Chem 1(10):10–36
  34. Najib, J. S. (2010). Efficacy and safety of zopiclone and eszopiclone in the treatment of primary and comorbid insomnia. GABA and Sleep: Molecular, Functional and Clinical Aspects. In: J.M. Monti et al. (eds.), GABA and Sleep.https://doi.org/10.1007/978-3-0346-0226-6_18, Springer Basel AG, pp 413-451 · DOI
  35. Ho JH, Wood DM, Archer JR, Dargan PI (2015) Availability of prescription zopiclone over the internet. BMJ 351:h5710. https://doi.org/10.1136/bmj.h5710 · DOI

Cited by

  • The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023

    Riemann, D., Espie, C. A., Altena, E., Arnardottir, E. S., Baglioni, C., Bassetti, C. L. A., Bastien, C., Berzina, N., Bjorvatn, B., Dikeos, D., et al. (2023) · Journal of Sleep Research · doi:10.1111/jsr.14035 · Cited by 834

    “Several very recent all-encompassing (network) meta-analyses included studies on fast-release, PR melatonin and ramelteon (De Crescenzo et al., 2022; Hasan et al., 2023; Maruani et al., 2023; Yue et al., 2023); however, the results are conflicting.”
    Background

See all 9

Metadata

Authors
Hasan, F., Lee, H.-C., Chen, P.-Y., Wang, Y.-H., Yuliana, L. T., Romadlon, D. S., Tu, Y.-K., & Chiu, H.-Y.
Venue
Sleep and Breathing
Published
2023-03-16
Volume
27
Issue
5
Pages
2021-2030
ISSN
  • 1520-9512
  • 1522-1709
Cited by
9
References
17
Language
en
Licence
Funders
Ministry of Science and Technology, Taiwan (111-2628-B- 038-008, 111-2314-B-038-033-MY3)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.